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Sepsis is a major cause of neonatal morbidity and mortality. In 2013, sepsis accounted for 15.6% of 2.8 million neonatal deaths and 47.6% of late neonatal deaths [1]. Estimates 
of neonatal sepsis (NS) burden vary by setting. Incidence of NS 
in India was 30/1000 live births and culture-proven sepsis was 
8.5/1000 live births and 2.3% of intramural live births according 
to the National Neonatal Perinatal Database (NNPD) report 
2002–2003 [2]. A study (2002–2005) from rural Orissa reports 
the incidence of culture-confirmed neonatal (0–28 days of life) 
sepsis as 4.6/1000 live births, 5.5% mortality for clinical NS, and 
10.3% mortality for culture-proven NS [3]. Investigators of the 
Delhi Neonatal Infection Study (DeNIS) collaboration found that, 
in the 13530 neonates who were enrolled of 88636 live births 
from 2011 to 2014, the incidence of total sepsis was 14.3% and of 
culture-positive sepsis was 6.2% of which 83% were early onset 
sepsis (EOS). The population attributable risks of mortality were 
8.6% in culture-negative sepsis, 15.7% in culture-positive sepsis 
by multidrug-resistant organisms, and 12.0% in culture-positive 
sepsis by non-multidrug-resistant organisms [4].
The clinical manifestations range from subclinical, nonspecific 
to severe manifestations. The organisms differ significantly 
between developed and developing countries [5]. Even among 
developing countries, regional variation exists [6]. In EOS (Sepsis 
within 72 h of birth), Gram-negative organisms such as Escherichia 
coli, Klebsiella, and Enterobacters are the prime cause of sepsis 
in India [7,8]. Some studies mention Gram-positive organisms as 
the chief cause, among which Staphylococcus aureus, coagulase-
negative staphylococci (CONS), Streptococcus virdans, and 
Group B Streptococci (GBS) are more common [9,10]. The 
organisms commonly associated with late-onset sepsis (LOS: 
Sepsis developing after >72 h of age) include CONS, S. aureus, 
Klebsiella pneumoniae, E. coli, Enterobacter spp., Pseudomonas 
aeruginosa, and Acinetobacter species [11]. NNPD database 
shows Klebsiella as the most common organism (32.5%) followed 
by S. aureus (13%) and E. coli (10.6%) [2].
We attempted this study as a concern about variable, and 
extended drug resistance is on the rise, and also treatment, 
policy decisions, rational use of antibiotics require updated 
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knowledge of common pathogens and their drug sensitivity 
pattern. The primary objective was to study the bacteriological 
profile and determine the antimicrobial sensitivity pattern of 
organisms causing NS. Secondary objectives were to study the 
various maternal and perinatal risk factors of NS and the clinical 
manifestations of NS.
METHODS
This prospective observational study was conducted at Niloufer 
Hospital, Hyderabad, for a period of 1 year from August 2016 
to July 2017. 300 neonates admitted with clinical suspicion of 
sepsis were included in the study. A data entry sheet was used 
to obtain patient details. Institutional Ethics Committee approval 
was obtained for the study. Clinical features of sepsis (lethargy, 
refusal to feed, abdominal distension, vomiting, respiratory 
distress, fever, hypothermia, convulsion, sclerema, apnea, and 
mottling) and risk factors for the sepsis (foul-smelling liquor/
meconium stained liquor, unclean vaginal examination done 
before delivery/>3 sterile vaginal examinations, prolonged 
labor, prolonged rupture of membranes, maternal pyrexia within 
2 weeks of labor, and birth asphyxia) were recorded.
Babies with birth weight <1000 g, neonates with obvious 
malformations/congenital anomalies were excluded. C-reactive 
protein (CRP) was done by latex agglutination test. Aerobic 
blood cultures were done and bacterial isolates, if identified were 
studied for antibiotic susceptibility by Kirby–Bauer disc diffusion 
method. Data were entered into an excel spreadsheet and group 
comparisons were done by applying t-test and χ2 (Chi-squared 
test). p<0.05 was taken as significant.
RESULTS
A total of 300 neonates were included in the study and the male 
to female ratio was 1.65:1. The percentage of septicemic preterm 
babies (39%) was higher than their proportion of 10–12% of all 
births. 40% had low birth weight (LBW), which was higher than 
their proportion of 25–30% of all births. The value of p was <0.05 
(calculated by one sample t-test) for gender, gestational age, birth 
weight, and onset of sepsis groups. Demographic characteristics, 
onset of sepsis, and culture details are given in Table 1.
EOS contributed to 54% of the cases. Blood cultures were 
positive in 39% of the cases. Perinatal risk factors responsible 
for the EOS are enumerated in Table 2, which shows that a very 
high proportion of the babies had these risk factors making them 
susceptible to sepsis. There was a coexistence of more than one 
factor in many cases.
The presentations of the babies with sepsis are given in Table 3. 
Refusal to feed and lethargy were the dominant presentations. 
More ominous features were observed in nearly 40% of the babies.
CRP was positive in 208 babies of the total of 300, of which 
114 were culture positive, and 94 were negative. In 92 babies with 
negative CRP, 3 were culture positive. Considering culture as the 
standard for diagnosis of NS, parameters for CRP derived were 
97.4% sensitivity, 48.6% specificity, 54.8% positive predictive 
value, and 96.7% negative predictive value. Of the 39% 
positive blood cultures, K. pneumoniae, CONS, Enterococcus, 
and S. aureus were the predominant isolates as shown in 
Table 4. Klebsiella was relatively more common in LOS while 
enterococcus was more frequent in EOS.
Tables 5 and 6 give the details of the bacterial isolates’ drug 
sensitivity patterns. As all isolates were not tested for all drugs, 
number of samples tested for a particular drug is mentioned in the 
tables along with percentage of sensitivity.
Excepting Enterococcus and Pseudomonas, all other 
organisms were sensitive to aminoglycosides. While cefotaxime 
and ampicillin had the lowest sensitivity, drugs with added 
penicillinases (Cefoperazone + Sulbactam and Piperacillin + 
Tazobactam) had better sensitivity. Levofloxacin had better 
Table 1: Characteristics of neonates and results of blood cultures
Gender Gestational age (weeks) Birth weight (kg) Onset of sepsis Blood culture
Male Female <37 >37 <2.5 >2.5 Early Late Growth No 
growth
187 (62%) 113 (38%) 117 (39%) 183 (61%) 120 (40%) 180 (60%) 162 (54%) 138 (46%) 117 (39%) 183 (61%)
p=0.000 p=0.000 p=0.000 p=0.049
Table 2: Perinatal risk factors for NS
Risk factors n (%)
Prolonged labor (>24 h) 77 (25.7)
Premature rupture of membrane (>18 h) 75 (25)
Maternal fever within 2 weeks (>38°C) 59 (19.7)
Foul-smelling liquor 54 (18)
Birth asphyxia 46 (15.3)
Unclean or >3 sterile vaginal examinations 15 (5)
NS: Neonatal sepsis
Table 3: Clinical manifestations in NS
Clinical features n (%)
Refusal of feed 230 (76.7)
Lethargy 199 (66.3)
Respiratory distress 120 (40)
Convulsion 114 (38)
Hypothermia 86 (28.7)
Mottling 86 (28.7)
Sclerema 82 (27.3)
Fever 66 (22)
Vomiting 57 (19)
Abdominal distension 57 (19)
Apnea 48 (16)
NS: Neonatal sepsis
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sensitivity than ciprofloxacin. Some isolates were resistant to 
carbapenems and vancomycin also.
DISCUSSION
NS being a life-threatening condition, changes in risk factors, 
etiology, and growing multidrug resistance must be properly 
addressed at each level of care. Considering this purpose, 
the present study looked at the said elements of concern. We 
observed male-female ratio as 1.65:1 (p<0.05) similar to other 
works (1.2:1–1.8:1) [15-18]. In contrast to it, one study reported 
a ratio of 1:1 [19]. As immunoglobulin genes are on chromosome 
X, females may be relatively resistant to infections. Notably, 39% 
were preterm in the study while their proportion being 10–12% 
Table 4: Bacteria isolated from cases of NS
Bacteria grown Total (%) EOS (%) LOS (%) Studies with similar results
K. pneumoniae 34 (29) 24 (37) 10 (19) [3,12,13]
CONS 26 (22) 14 (22) 12 (22) [3,12]
Enterococcus 24 (20) 9 (14) 15 (28) [3,12,14]
S. aureus 14 (12) 6 (9) 8 (15) [3,13]
P. aeruginosa 8 (7) 5 (8) 3 (6) [13]
Acinetobacter 7 (6) 5 (8) 2 (4) [13]
E. coli 2 (2) 2 (4) [13]
GBS 2 (2) 1 (2) 1 (2)
NS: Neonatal sepsis, K. pneumoniae: Klebsiella pneumoniae, CONS: Coagulase‑negative staphylococci, S. aureus: Staphylococcus aureus, P. aeruginosa: Pseudomonas aeruginosa, 
E. coli: Escherichia coli, GBS: Group B streptococci
Table 5: Antibiotic sensitivity pattern of bacteria in NS
Antibiotic Organism‑wise number of samples showing sensitivity/total samples tested (% sensitivity)
Klebsiella CONS Enterococcus S. aureus
Amikacin 25/34 (73.5) 20/26 (76.9) 4/20 (20) 12/14 (85.7)
Netilmicin 26/34 (76.5) 23/26 (88.5) 6/22 (27.3) 14/14 (100)
Cefoperazone sulbactam 10/34 (29.4) 4/16 (25) - 6/12 (50)
Gentamicin 19/30 (63.3) 5/26 (19.2) 8/20 (40) 7/12 (58.3)
Cefotaxime 3/25 (12) 3/15 (20) 0/12 (0) 3/12 (25)
Ciprofloxacin 6/24 (25) 14/23 (60.8) 0/7 (0) -
Ampicillin 4/32 (12.5) 3/15 (20) 0/11 (0) 2/13 (15.4)
Imipenem 19/29 (65.5) - - -
Meropenem 23/26 (88.5) - - -
Piperacillin-tazobactam 20/30 (66.7) - - -
Vancomycin - 23/26 (88.5) 23/23 (100) 13/14 (92.8)
Levofloxacin - 13/16 (81.3) 3/15 (20) 9/12 (75)
NS: Neonatal sepsis, CONS: Coagulase‑negative staphylococci, S. aureus: Staphylococcus aureus
Table 6: Antibiotic sensitivity pattern of bacteria in NS
Antibiotic Organism‑wise number of samples showing sensitivity/total samples tested (% sensitivity)
Pseudomonas Acinetobacter E. coli GBS
Amikacin 1/6 (16.7) 4/7 (57.1) 2/2 (100) -
Netilmicin 2/5 (40) 3/3 (100) 2/2 (100) 2/2 (100)
Cefaperazone-sulbactam 0/3 (0) 4/4 (100) - -
Gentamicin 2/7 (28.6) 4/7 (57.1) 2/2 (100) 2/2 (100)
Cefotaxime - 0/4 (0) 0/2 (0) 0/2 (0)
Ciprofloxacin - 3/6 (50) - 2/2 (100)
Ampicillin 0/4 (0) 4/4 (100) 0/1 (0) -
Imipenem 8/8 (100) 7/7 (100) 2/2 (100) -
Meropenem 7/8 (87.5) 7/7 (100) 2/2 (100) -
Piperacillin tazobactam 7/8 (87.5) 6/7 (85.7) 2/2 (100) -
Vancomycin - - - 2/2 (100)
Levofloxacin - - - 2/2 (100)
NS: Neonatal sepsis, E. coli: Escherichia coli, GBS: Group B streptococci
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of all births correlating with similar observations in two previous 
studies (32% and 39%) [19,20]. Prematurity and LBW coexist, and 
40% cases were LBW which is similar to other studies [20-22].
Nearly 54% were EOS, while 46% were LOS (p<0.05) and a 
higher incidence of EOS was also observed elsewhere [4,23,24]. 
Conversely, some reported a higher incidence of LOS [6]. In 
developed countries, the proportion of EOS is in the range of 
10–20% [25,26]. Perinatal risk factors have a significant impact 
on the incidence of EOS. There is a huge difference in the 
incidence of EOS in between India and developed countries, 
which clearly emphasizes the need for reduction of perinatal 
risk factors for sepsis in India. PROM (25 %) and prolonged 
labor (25.7%) were the major perinatal risk factors, which were 
similar to two studies [19,21]. There was the coexistence of 
more than one factor in several cases. Refusal to feed (76.7%) 
was the most common mode of presentation as seen in other 
studies (75–92%). Rests of the clinical features were also 
similar in frequencies to other works [12,19,20]. CRP was 
positive in 69.3% of the clinical sepsis cases. CRP had good 
sensitivity and negative predictive value than specificity and 
positive predictive value when culture is taken as standard 
similar to previous observations [27,28]. This implies when 
CRP is negative, culture is negative most of the times, but CRP 
positivity does not denote culture positivity.
The culture positivity rate (39%) depends on a multitude of 
factors. Studies showed culture positivity rates in the same range 
(28.6–47.5%) [2,29,30]. Klebsiella was the most frequently 
isolated organism in this study, whereas E. coli was the most 
common organism in the past [8,15]. GBS which is one of the 
most common isolates in West was not grown in significant 
numbers in any Indian study. Enterococcus has emerged as a 
major pathogen which is associated with LOS in preterms and 
nosocomial infections. The frequencies of bacterial isolates are 
comparable to studies in India and abroad, references of which 
are included in Table 4.
A survey of the studies reveals varying predominance of 
microbes at different times and places and even within the same 
setup. Hence, in any NICU, it is very essential to have periodic 
survey to define the organisms and their sensitivity pattern. 
Antibiotic sensitivity pattern varied among studies probably due 
to the antibiotic usage differences. Drugs used for sensitivity 
testing were also not the same in all the studies. A comparison of 
antibiotic sensitivity of organisms among North and South Indian 
studies is presented in Table 7, which illustrates the differences 
Table 7: Comparison of antibiotic sensitivity of organisms among North and South Indian studies
Organism Sensitivity 
highest (H)
Lowest (L)
Present study Marwah et al.[31] 
GMCH, Chandigarh
Leela et al.[32] Govt. 
Kilpauk Medical College, 
Chennai
Sathyamurthi et al.[33] 
Government Kilpauk 
Medical College, 
Chennai
K. Pneumoniae H Meropenem (88.5%) Vancomycin and 
linezolid (100%)
Cefmetazole (100%), 
Amikacin (90.9%) 
Cefoperazone-sulbactam
Piperacillin tazobactam
Ciprofloxacin
L Cefotaxime
(12%)
Ceftazidime (0%) Ampicillin (0%) Imipenem 
third-generation 
Cephalosporins
CONS H Vancomycin and 
netilmycin (88.5%)
Vancomycin and 
amikacin (100%)
Vancomycin (90%)
L Gentamycin (19.2%) Ampicillin (0%) Ceftriaxone (5%)
S. aureus H Netilmicin (100%), 
vancomycin (92.8%)
aminoglycosides, 
vancomycin and
linezolid
Vancomycin and 
amikacin (100%)
Vancomycin (96.15%)
L Cefotaxime (25%),
Ampicillin (15.4%)
oxacillin Ciprofloxacin (0%) Cefaperazone (3.84%)
P. monas H Imipenem (100%), 
meropenem (87.5%)
Piperacillin 
tazobactam (87.5%)
second and third-generation 
cephalosporins, 
Cefoperazone-sulbactam, 
Amikacin and Ciprofloxacin
Imipenem (71.42%)
L Ampicillin (0%) Ampicillin, Gentamicin Ampicillin (14.28%)
A. bacter H Ampicillin and 
meropenem (100%)
Colistin
Polymyxin B
Ceftazidime (100%), 
Cefoperazone-sulbactam, 
amikacin (100%)
Imipenem (76.15%)
L Cefotaxime (0%) Gentamicin
Ampicillin
Ciprofloxacin (0%) Vancomycin (4.16%)
E. coli H Imipenem and 
amikacin (100%)
Imipenem (85.7%) Cefoperazone-sulbactam Imipenem (75%)
L Cefotaxime (0%), 
ampicillin (0%)
Ampicillin (0%) Gentamycin (25%)
K. pneumoniae: Klebsiella pneumoniae, CONS: Coagulase‑negative staphylococci, S. aureus: Staphylococcus aureus, P. aeruginosa: Pseudomonas aeruginosa, E. coli: Escherichia 
coli, A. bacter: Acinetobacter
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from center to center and differences at the same center, and also 
gives an idea of sensitivities across India.
GBS showed 100% sensitivity to gentamicin and vancomycin 
while no sensitivity to cefotaxime.
A population-based study of NS in 223 villages of Odisha 
state recorded a very high level of resistance to penicillin and 
ampicillin, moderate resistance to cephalosporins, and extremely 
low resistance to gentamicin, amikacin, and 2nd generation 
cephalosporins. No resistance was seen to imipenem or 
vancomycin; although 27% of the S. aureus isolates were 
intermediate sensitive to vancomycin. High numbers of the Gram-
negative organisms were extended-spectrum beta-lactamase 
producers and harbored multidrug resistance. Removal of an 
antibiotic from the therapeutic regimen may lead to a reversal 
of microbial resistance resulting in susceptible phenotypes [3]. 
Amikacin, the most widely used semisynthetic aminoglycoside, 
is refractory to most aminoglycoside modifying enzymes except 
acetylation by the aminoglycoside 6’-N-acetyltransferase 
Type Ib [AAC(6’)-Ib] [34].
In the present study, Netilmicin and amikacin showed 
good sensitivity to most of the isolates except enterococcus 
and pseudomonas. Imipenem, meropenem, and piperacillin-
tazobactam showed good sensitivity to Gram-negative 
organisms. Gram-positive organisms were sensitive to 
vancomycin. Most of the bacterial isolates were resistant to 
cefotaxime and ampicillin. Limitations of the study are not 
using fungal and anaerobic organisms’ culture methods, not 
testing antibiotic sensitivity of isolates with a similar set of 
antibiotics, and all the bacterial isolates were not tested by a 
given antibiotic.
Using the combination of biomarkers to shorten the response 
times in diagnosis and treatment is of immense value as the 
presentation of NS is ambiguous and there may be a delay in its 
detection. Modern molecular methods on the direct sample or the 
identification by MALDI-TOF on positive blood culture help in 
optimizing the antibiotic treatment and facilitating stewardship 
programs. Establishing a sepsis code to decrease the time to 
achieve diagnosis and to treat, and to improve organization, unify 
criteria, promote teamwork and also commitment from health 
administration can reduce morbidity and mortality due to NS by 
great degree [35,36].
CONCLUSIONS
This study revealed variation in antibiotic susceptibility pattern 
among bacterial isolates and also showed that third-generation 
cephalosporins and penicillins are no more effective in treating 
NS. Addition of penicillinase inhibitors to them is advocated. 
Aminoglycosides, as first-line antibiotics are still effective. 
Review of antibiotics every 48–72 h, in view of high drug 
resistance, is critical. Recognizing NS as a seriously concerning 
public health problem and implementing measures aimed at 
changes in health systems and personnel are imperative to reduce 
neonatal mortality.
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